GeminIQ Website Logo

Viewing BCYC free

Subscribe for full history, 50+ metrics, screener, watchlist...

BICYCLE THERAPEUTICS PLC

BCYC

Companies in Pharmaceutical Preparations

BICYCLE THERAPEUTICS PLC (BCYC) — SEC Financial Statements & Analysis

BICYCLE THERAPEUTICS PLC (BCYC) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
559628648721793880891961457526572340
Accounts Receivable Net Current
----0--0-0045
Prepaid Expense And Other Assets Current
191923221713172020111410
Assets Current
6196837398048569299661,028516562603408
Property Plant And Equipment Net
6678910121213151618
Operating Lease Right Of Use Asset
1516567891112131516
Other Assets Noncurrent
13131414121110766512
Assets
6527187648328849579971,057547595639454
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
610131811166771385
Accrued Liabilities Current
404444453441392826323437
Deferred Revenue Current
3312151310111216252730
Long Term Debt Current
-------22----
Liabilities Current
495769775867567050707072
Long Term Debt Noncurrent
-------931313131
Operating Lease Liability Noncurrent
1414123467891012
Deferred Revenue Noncurrent
343674838291989498110108115
Other Liabilities Noncurrent
111111655544
Liabilities
98108145163144164166184191224223234
Stockholders Equity
Common Stock Value
111111111110
Additional Paid In Capital
1,5191,5121,5011,4921,4821,4731,4621,452895883875633
Accumulated Other Comprehensive Income Loss Net Of…
-5-4-3-3-10-3-1-1-13-1
Retained Earnings Accumulated Deficit
-961-900-880-820-742-681-629-578-538-512-463-413
Stockholders Equity
554610618669740793831874356371416220
Liabilities And Stockholders Equity
6527187648328849579971,057547595639454
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
163160160160159156156154186179179179
Common Stock Shares Issued
706969696969696985858592
Shares Outstanding
706969696969696985858592

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-3.60%-15.25%----------
2025-11.34%-18.28%-5.73%-3.53%-3.27%3.01%-27.85%-21.58%-25.68%-2.56%-5.13%-17.16%
2024-6.72%-16.85%-9.56%-11.81%-4.80%1.44%-12.39%-37.39%-43.10%-18.20%-33.42%-27.03%
202315.89%21.05%21.53%1.43%-13.18%-26.02%-7.18%25.22%19.05%4.72%-1.72%0.88%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
12.66
11.98
10.66
10.39
14.86
13.81
17.13
14.77
10.42
8.08
8.65
5.65
Quick Ratio
12.28
11.65
10.33
10.10
14.57
13.61
16.82
14.48
10.02
7.92
8.45
5.51
Working Capital
570.25M
625.90M
669.54M
726.84M
798.46M
861.38M
909.79M
958.65M
466.45M
492.33M
533.30M
336.16M
Leverage & Debt
Debt to Equity
0.18
0.18
0.24
0.24
0.19
0.21
0.20
0.21
0.54
0.60
0.54
1.06
Interest Coverage TTM
-
-
-
-
-
-255.63
-119.71
-74.70
-54.90
-58.21
-51.37
-44.89
Debt Ratio
0.15
0.15
0.19
0.20
0.16
0.17
0.17
0.17
0.35
0.38
0.35
0.52
Efficiency & Turnover
Asset Turnover TTM
0.08
0.09
0.03
0.02
0.04
0.05
0.05
0.05
0.09
0.05
0.05
0.05
Days Sales Outstanding TTM
-
-
-
-
1.93
-
-
209.01
-
-
-
446.48
Receivables Turnover TTM
-
-
-
-
189.13
-
-
1.75
-
-
-
0.82
Per Share Metrics
Diluted EPS TTM
-3.14
-3.16
-3.62
-3.50
-2.94
-2.90
-2.41
-3.18
-3.95
-5.08
-4.08
-4.64
Free Cash Flow Per Share TTM
-3.32
-3.64
-3.49
-3.04
-2.63
-2.85
-2.95
-3.17
-2.02
-1.79
-1.21
-1.83
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
-
-
-
-
-
-
-
-
107.87%
112.10%
113.17%
114.53%
Operating Profit Margin TTM
-381.67%
-340.38%
-1,023.40%
-1,495.33%
-965.55%
-594.96%
-532.40%
-463.42%
-432.25%
-704.13%
-676.29%
-652.30%
Net Profit Margin TTM
-344.95%
-301.66%
-884.51%
-1,257.00%
-790.07%
-479.18%
-450.64%
-417.88%
-404.14%
-669.72%
-650.60%
-621.69%
Growth Metrics
Net Revenue Growth (1Y)
146.85%
105.77%
-23.20%
-51.28%
-38.18%
30.76%
48.60%
75.74%
168.47%
86.52%
64.99%
37.79%
Net Income Growth (1Y)
7.78%
29.54%
50.75%
46.56%
20.85%
-6.44%
2.93%
18.13%
35.38%
60.28%
60.30%
60.71%
EPS Growth (1Y)
7.03%
8.84%
50.06%
10.03%
-25.67%
-42.79%
-40.95%
-31.40%
-4.57%
33.57%
20.20%
57.82%
Valuation Metrics
P/E TTM
-1.48
-2.24
-2.14
-1.99
-2.89
-4.82
-9.39
-6.36
-6.30
-3.56
-4.92
-5.50
P/B
0.58
0.80
0.87
0.72
0.79
1.03
1.88
1.20
2.98
1.73
1.91
3.50
P/S TTM
5.09
6.76
18.93
24.96
22.84
23.10
42.31
26.59
25.47
23.85
32.02
34.22
Market Cap
323.33M
490.50M
536.41M
481.30M
587.48M
814.91M
1.56B
1.05B
1.06B
643.51M
795.09M
770.49M
Enterprise Value
-236.75M
-138.21M
-112.46M
-240.70M
-206.04M
-65.16M
669.81M
121.32M
633.00M
147.24M
253.06M
460.57M
Calculated Values
Free Cash Flow TTM
-231.69M
-252.03M
-241.87M
-210.29M
-182.05M
-165.96M
-203.53M
-164.79M
-85.93M
-63.56M
-47.98M
-55.30M
Net Debt
-560.08M
-628.72M
-648.87M
-722.00M
-793.52M
-880.07M
-891.41M
-931.00M
-426.74M
-496.27M
-542.03M
-309.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-04-06Sale
Owner: Thompson, Travis Alvin
Title: Chief Financial Officer
Shares: 102
Price/Share: $5.05
Value: $515.10
Shares Owned: 65,364
Relationship: Officer
Ownership: Direct
2026-04-06Sale
Owner: Skynner, Michael
Title: CHIEF SCIENTIFIC OFFICER
Shares: 525
Price/Share: $5.05
Value: $2,651.25
Shares Owned: 159,562
Relationship: Officer
Ownership: Direct
2026-04-06Sale
Owner: Hannay, Michael Charles F…
Title: CHIEF PROD & SUPPLY CHAIN OFF
Shares: 251
Price/Share: $5.05
Value: $1,267.55
Shares Owned: 96,136
Relationship: Officer
Ownership: Direct
2026-04-06Sale
Owner: Lee, Kevin
Title: CHIEF EXECUTIVE OFFICER
Shares: 1,716
Price/Share: $5.05
Value: $8,665.80
Shares Owned: 611,313
Relationship: Director,Officer
Ownership: Direct
2026-04-06Sale
Owner: Perry, Jennifer Scott
Title: Chief Operating Officer
Shares: 370
Price/Share: $5.04
Value: $1,864.80
Shares Owned: 92,464
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
48.75%
Inst. Shares: 33,973,645
Shares Outstanding: 69,683,471
2025-12-31
51.20%
Inst. Shares: 35,468,035
Shares Outstanding: 69,279,838
2025-09-30
49.02%
Inst. Shares: 33,971,240
Shares Outstanding: 69,303,746
2025-06-30
52.53%
Inst. Shares: 36,377,698
Shares Outstanding: 69,252,009
2025-03-31
52.50%
Inst. Shares: 36,330,227
Shares Outstanding: 69,196,945

Research Faster.
Invest Smarter.

BICYCLE THERAPEUTICS PLC (BCYC) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.